Hearing in Children with Phenylketonuria

Siamak Shiva, Yalda Jabbari Moghaddam

Abstract


Background: Phenylalanine is an essential Acid Amine participates in protein synthesis by tyrosine. High levels of phenylalanine in the body lead to the production of large quantities of phenyl ketone, which is excreted through urine and that is why it called as Phenylketonuria. A defect of IQ and attention, visual ability and speech processing in this patient. the aim of this study was hearing threshold evaluation of this patient. Method: In a cross-sectional, descriptive study auditory brain stem responses and otoacoustic emission of patients from 1 to13 years and control group age range of 1 to 14 years evaluated. Results: In 31 patients (62%) delay in ABR waves were outside of the normal range but the overall mean of all waves had in the normal range and the average interval of waves in patients with delay in treatment delay was more than patients group with early treatment. Conclusion: delayed-treatment was faced with more delays in the intervals between ABR waves, although statistically was not significant.

Keywords


ABR, PKU, OAE

Full Text:

PDF

References


Nelson Textbook of Pediatrics, 19th edition, chapter 79, pages 418-421

Diamond, A., Prevor, M. B., Callender, G., et al. (1997). Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev, 62, i–v, 1.

Anderson, P. J., Wood, S. J., Francis, D. E., et al. (2007). Are neuropsychological impairments in children with early-treated phenylketonuria(PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol, 32, 645–668.

Scriver, C. R., & Kaufman, S. (2001). Hiperphenylalaninemia: Phenylalanine hydroxilase deficiency. In C. R. Scriver, et al. (Eds). The Metabolic and Molecular Bases of Inherited Disease (8th ed.) (1667–1724).

Malloy-Diniz, L. F., Cardoso-Martins, C., Carneiro, K. C., et al. (2004). [Executive functions in children with phenylketonuria: Variations as a function of phenilalanine plasm level]. Arq Neuropsiquiatr, 62(2B), 473–479.

Durrant, J. D., & Ferraro, J. A. (2001). Potenciais auditivos evocados de curta latência: Eletrococleografia e audiometria de tronco encefálico. In F. E. Musiek & W. F. Rintelmann (Eds). Perspectivas Atuais em Avaliação Auditiva (193–238). Barueri, SP: Manole.

Musiek, F., Borenstein, S. P., Hall, J. W., Schwaber, M. (1999a). Auditory brainstem response (ABR): Neurodiagnostic and intraoperative aplications. In J. Katz (Ed). Handbook of Clinical Audiology (4th ed.) (349–371). São Paulo, Brazil: Ed. Manole.

Azadi, B., Seddigh, A., Tehrani-Doost, M., et al. (2009). Executive dysfunction in treated phenylketonuric patients. Eur Child Adolesc Psychiatry, 18, 360–368.

Kanufre, V. C., Santos, J. S., Soares, R. D. L, et al. (2001). Dietary approach for phenylketonuria. Rev Méd Minas Gerais, 11, 129–133.

Shaw, V., & Lawson, M. (1994). Clinical Paediatric Dietetics. London, UK: Blackwell Science, Inc.

Mira, N. V., & Marquez, U. M. (2000). [Importance of the diagnoses and treatment of phenylketonuria]. Rev Saude Publica, 34, 86–96.

VanZutphen, K. H., Packman, W., Sporri, L., et al. (2007). Executive functioning in children and adolescents with phenylketonuria. Clin Genet, 72, 13–18.

DeRoche, K., & Welsh, M. (2008). Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: Intelligence and executive function. Dev Neuropsychol, 33, 474–504.

Williams, R. A., Mamotte, C. D., Burnett, J. R. (2008). Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev, 29, 31–41.

Santos, L. L., Magalhães, M. D. E. C., Januário, J. N., et al. (2006). The time has come: a new scene for PKU treatment. Genet Mol Res, 5, 33–44.

Korinthenberg, R., Ullrich, K., Füllenkemper, F. (1988). Evoked potentials and electroencephalography in adolescents with phenylketonuria. Neuropediatrics, 19, 175–178.

Cardona, F., Leuzzi, V., Antonozzi, I., et al. (1991). The development of auditory and visual evoked potentials in early treated phenylketonuric children. Electroencephalogr Clin Neurophysiol, 80, 8–15.

Ludolph, A. C., Ullrich, K., Nedjat, S., et al. (1992). Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. A clinical and electrophysiological study. Acta Neurol Scand, 85, 243–248.

Leuzzi, V., Cardona, F., Antonozzi, I., et al. (1994). Visual, auditory, and somatosensorial evoked potentials in early and late treated adolescents with phenylketonuria. J Clin Neurophysiol, 11, 602–606.

Ludolph, A. C., Vetter, U., Ullrich, K. (1996). Studies of multimodal evoked potentials in treated phenylketonuria: The pattern of vulnerability. Eur J Pediatr, 155 suppl 1, 64–68.

Patricia C. M., John D. D, Ana L. P S, Maria C. M. I. (2013). Children With Phenylketonuria Treated Early: Basic Audiological and Electrophysiological Evaluation. 0196/0202/13/3402-0236/0 • Ear and Hearing • Copyright © 2013 by Lippincott Williams & Wilkins • Hagerstown, MD

Cummings otolaryngology head and neck surgery, 16th edition, ISBN: 978-1-4557-4696-5, Copyright © 2015 by Saunders, an imprint of Elsevier Inc, chapter 133, pages 2063-2064

Siamak S., Mohammad B., Erfan S., Giti S. G.(2011). Seizure Frequency and Electroencephalographic Findings in Children with Phenylketonuria. Medical Journal Of Tabriz University Of Medical Sciences, 33, 37-41




DOI: http://dx.doi.org/10.7575/aiac.abcmed.v.6n.3p.16

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2018 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine